 |
市场调查报告书
商品编码
1741168
电转化细胞市场，按应用、细胞类型、转化效率、包装形式、最终用户和地区划分Electrocompetent Cells Market, By Application, By Cell Type, By Transformation Efficiency, By Packaging Format, By End User, By Geography |
||||||
价格
简介目录
预计 2025 年电转化细胞市场规模为 25.3 亿美元，到 2032 年将达到 50.9 亿美元，2025 年至 2032 年的复合年增长率为 10.5%。
| 报告范围 | 报告详细信息 | ||
|---|---|---|---|
| 基准年 | 2024 | 2025年的市场规模 | 25.3亿美元 |
| 效能数据 | 2020-2024 | 预测期 | 2025-2032 |
| 预测期：2025-2032年复合年增长率： | 10.50% | 2032年价值预测 | 50.9亿美元 |
电穿孔感受态细胞是透过电穿孔技术製备的可吸收DNA的细菌细胞。电穿孔技术将细胞暴露于电场中，在细胞膜上产生暂时的孔洞。这使得外来DNA能够进入细胞并整合到细胞自身的DNA中。电穿孔感受态细胞具有广泛的应用，特别是在生物技术和基因工程领域。外来DNA插入细胞后，在细胞内复製，产生插入DNA的多个拷贝。这些拷贝可用于生产蛋白质。电穿孔感受态细胞也用于基因工程，以创造基因改造生物。在农业领域，它可以用于培育具有所需性状的作物，在医学领域，它可以用于培育能够产生治疗性蛋白质的细菌。
市场动态：
分子克隆研究领域的研究和资金投入日益增加，预计将推动对感受态细胞的需求，因为它们在各种生物技术程序中都具有极高的效率。这些因素预计将在预测期内支撑全球电感受态细胞市场的成长。
然而，对具有扎实技术知识的熟练专业人员的需求是预测期内阻碍全球电转化细胞市场成长的主要因素之一。
本研究的主要特点
- 本研究报告对全球电转化细胞市场进行了详细分析，并提供了预测期 2025-2032（以 2024 年为基准年）的市场规模和年复合成长率（CAGR%）。
- 它还强调了各个领域的潜在商机，并说明了该市场的有吸引力的投资提案矩阵。
- 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的主要考察。
- 全球电转化细胞市场的主要企业是根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数进行的分析。
- 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
- 本研究报告针对该产业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
- 相关人员将透过用于分析全球电转化细胞市场的各种策略矩阵来做出决策。
目录
第一章 调查目的与前提条件
- 研究目标
- 先决条件
- 简称
第二章 市场展望
- 报告描述
- 市场定义和范围
- 执行摘要
- Coherent Opportunity Map（COM）
第三章市场动态、法规与趋势分析
- 市场动态
- 驱动程式
- 分子克隆研究的研究和资助活动增加
- 增加基因治疗的投资
- 限制因素
- 专业技能人才短缺
- 机会
- 重组DNA技术的进展
- 影响分析
- 主要亮点
- 监管情景
- 产品发布/核准
- PEST分析
- 波特分析
- 併购场景
4. 电转化细胞市场-冠状病毒（COVID-19）大流行的影响
- COVID-19流行病学
- 供需侧分析
- 经济影响
5. 电转化细胞市场（依应用划分），2020 年至 2032 年
- 复製
- 蛋白质表现
- 诱变
- 基因组DNA文库构建
- 抗体产生
- 高通量筛检
- 其他的
6. 电转化细胞市场（依细胞类型），2020-2032
- 大肠桿菌（E. coli）
- 酿酒酵母（S. cerevisiae）
- 枯草桿菌（B. subtilis）
- 恶臭假单胞菌（P. putida）
- 肺炎链球菌
- 其他的
7. 2020 年至 2032 年电转化细胞市场（依转化效率）
- 高效率电池
- 超高效率电池
8. 2020 年至 2032 年以包装形式分類的电转化细胞市场
- 管子
- 盘子
- 自订格式
9. 2020 年至 2032 年电转化细胞市场（依最终用户划分）
- 製药和生物技术公司
- 学术研究所
- 合约研究组织（CRO）
- 其他的
10. 2020-2032 年电转化细胞市场（按地区）
- 北美洲
- 美国
- 加拿大
- 欧洲
- 德国
- 英国
- 西班牙
- 法国
- 义大利
- 俄罗斯
- 其他欧洲国家
- 亚太地区
- 中国
- 印度
- 日本
- 澳洲
- 韩国
- ASEAN
- 其他亚太地区
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
- 非洲
- 海湾合作委员会国家
- 以色列
- 其他中东地区
- 非洲
- 南非
- 北非
- 中部非洲
第十一章竞争格局
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Agilent Technologies, Inc.
- QIAGEN NV
- New England Biolabs, Inc.
- GenScript Biotech Corporation
- Lucigen Corporation
- Takara Bio Inc.
- Delphi Genetics SA
- IBA GmbH
- Scarab Genomics LLC
- Zymo Research Corporation
- Bioline GmbH（Meridian Bioscience）
- SelectScience
- Biosearch Technology
第十二章 章节
- 调查方法
- 关于出版商
简介目录
Product Code: CMI5897
Electrocompetent Cells Market is estimated to be valued at USD 2.53 Bn in 2025 and is expected to reach USD 5.09 Bn by 2032, growing at a compound annual growth rate (CAGR) of 10.5% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 2.53 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 10.50% | 2032 Value Projection: | USD 5.09 Bn |
Electrocompetent cells are bacterial cells that have been prepared for the uptake of DNA through electroporation, a process that involves exposing the cells to an electric field that creates temporary pores in the cell membranes. This allows foreign DNA to enter the cell, which can then be incorporated into the cell's own DNA. This technique is commonly used in molecular biology for cloning purposes, and the cells are often used in research and development in the biotechnology and pharmaceutical industries. electrocompetent cells have a wide range of applications, particularly in the field of biotechnology and genetic engineering. here are some of the key applications,.such as cloning, electrocompetent cells are often used in cloning experiments. The foreign DNA is inserted into the cells, which then replicate, producing many copies of the inserted DNA. They are used in the production of proteins. Moreover, electrocompetent cells are used in genetic engineering to create genetically modified organisms. This can be used in agriculture to create crops with desirable traits, or in medicine to create bacteria that produce therapeutic proteins.
Market Dynamics:
There is a rise in research activities and funding activities in molecular cloning studies. This in turn is expected to boost the demand for competent cells, as they are highly efficacious in various biotechnology procedures. This factor is expected to support the growth of the global electrocompetent cells market over the forecast period.
However, the need for skilled professionals with sound technical knowledge is one of the major factors expected to hamper growth of the global electrocompetent cells market over the forecast period.
Key features of the study:
- This report provides in-depth analysis of the global electrocompetent cells market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global electrocompetent cells market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies, Inc., QIAGEN N.V., New England Biolabs, Inc., GenScript Biotech Corporation, Lucigen Corporation, Takara Bio Inc., Delphi Genetics S.A., IBA GmbH, Scarab Genomics LLC, Zymo Research Corporation, Bioline GmbH (Meridian Bioscience), SelectScience and Biosearch Technology.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global electrocompetent cells market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global electrocompetent cells market
Global Electrocompetent Cells Market Detailed Segmentation:
- By Application:
- Cloning
- Protein Expression
- Mutagenesis
- Genomic DNA Library Construction
- Antibody Production
- High-Throughput Screening
- Others
- By Cell Type
- Escherichia coli (E. coli)
- Saccharomyces cerevisiae (S. cerevisiae)
- Bacillus subtilis (B. subtilis)
- Pseudomonas putida (P. putida)
- Streptococcus pneumoniae (S. pneumoniae)
- Others
- By Transformation Efficiency:
- High Efficiency Cells
- Ultra-High Efficiency Cells
- By Packaging Format:
- Tubes
- Plates
- Custom Formats
- By End User:
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Contract Research Organizations (CROs)
- Others
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
- Company Profiles:
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Agilent Technologies, Inc.
- QIAGEN N.V.
- New England Biolabs, Inc.
- GenScript Biotech Corporation
- Lucigen Corporation
- Takara Bio Inc.
- Delphi Genetics S.A.
- IBA GmbH
- Scarab Genomics LLC
- Zymo Research Corporation
- Bioline GmbH (Meridian Bioscience)
- SelectScience
- Biosearch Technology
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Electrocompetent Cells, By Application
- Market Electrocompetent Cells, By Cell Type
- Market Electrocompetent Cells, By Transformation Efficiency
- Market Electrocompetent Cells, By Packaging Format
- Market Electrocompetent Cells, By End User
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Rise in research activities and funding activities in molecular cloning studies
- Increasing investments in gene therapy
- Restraints
- Lack of skilled professionals
- Opportunities
- Advancements in recombinant DNA technology
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Electrocompetent Cells Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Electrocompetent Cells Market , By Application, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- Cloning
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Protein Expression
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Mutagenesis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Genomic DNA Library Construction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Antibody Production
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- High-Throughput Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
6. Electrocompetent Cells Market, By Cell Type, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2023and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Escherichia coli (E. coli)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Saccharomyces cerevisiae (S. cerevisiae)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Bacillus subtilis (B. subtilis)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Pseudomonas putida (P. putida)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Streptococcus pneumoniae (S. pneumoniae)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
7. Electrocompetent Cells Market, By Transformation Efficiency, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2023and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- High Efficiency Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Ultra-High Efficiency Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
8. Electrocompetent Cells Market, By Packaging Format, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2023and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- Tubes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Plates
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Custom Formats
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
9. Electrocompetent Cells Market, By End User, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2023and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
10. Electrocompetent Cells Market, By Region, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2023and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021-2032
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Transformation Efficiency, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Format, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Transformation Efficiency, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Format, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Transformation Efficiency, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Format, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Transformation Efficiency, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Format, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Transformation Efficiency, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Format, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Transformation Efficiency, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Format, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Agilent Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- QIAGEN N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- New England Biolabs, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- GenScript Biotech Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Lucigen Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Takara Bio Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Delphi Genetics S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- IBA GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Scarab Genomics LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Zymo Research Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bioline GmbH (Meridian Bioscience)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- SelectScience
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Biosearch Technology
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
12. Section
- Research Methodology
- About us
